Cite
Secondary acute myeloid leukaemia after peptide receptor radionuclide therapy.
MLA
Piccin A, et al. “Secondary Acute Myeloid Leukaemia after Peptide Receptor Radionuclide Therapy.” Annals of Hematology, vol. 91, no. 2, Feb. 2012, pp. 299–300. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=104439862&authtype=sso&custid=ns315887.
APA
Piccin A, Grana CM, Negri G, Pusceddu I, Paganelli G, & Cortelazzo S. (2012). Secondary acute myeloid leukaemia after peptide receptor radionuclide therapy. Annals of Hematology, 91(2), 299–300.
Chicago
Piccin A, Grana CM, Negri G, Pusceddu I, Paganelli G, and Cortelazzo S. 2012. “Secondary Acute Myeloid Leukaemia after Peptide Receptor Radionuclide Therapy.” Annals of Hematology 91 (2): 299–300. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=104439862&authtype=sso&custid=ns315887.